Falcon Wealth Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
1,288
-36
-3% -$36.8K 0.1% 72
2026
Q1
$1.22M Buy
1,324
+70
+6% +$71K 0.08% 76
2025
Q4
$1.35M Buy
1,254
+171
+16% +$164K 0.11% 65
2025
Q3
$826K Buy
1,083
+99
+10% +$73.7K 0.07% 84
2025
Q2
$767K Buy
984
+16
+2% +$12.4K 0.08% 80
2025
Q1
$800K Buy
968
+85
+10% +$70.7K 0.09% 72
2024
Q4
$682K Buy
883
+144
+19% +$119K 0.08% 80
2024
Q3
$655K Sell
739
-6
-0.8% -$5.39K 0.08% 76
2024
Q2
$675K Buy
745
+70
+10% +$56K 0.09% 65
2024
Q1
$525K Buy
675
+33
+5% +$23.5K 0.08% 80
2023
Q4
$374K Buy
+642
New +$375K 0.07% 89

Other funds holding LLY

Falcon Wealth Planning's LLY Position: Q2 2026 in Review

Falcon Wealth Planning reduced its Eli Lilly (LLY) stake by 2.7% in Q2 2026, selling an estimated $36.8K and leaving 1,288 shares worth $1.55M. The position accounts for 0.1% of the portfolio, ranked #72.

Falcon Wealth Planning first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,651 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Falcon Wealth Planning held 1,288 shares of Eli Lilly worth $1.55M as of Q2 2026.
  • Falcon Wealth Planning sold 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.1% of Falcon Wealth Planning's portfolio in Q2 2026, its #72 holding.
  • Falcon Wealth Planning first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,651 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Falcon Wealth Planning's 13F filing for Q2 2026, filed 13 Jul 2026.